Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Transplantation
    May 2018
  1. YILDIRIM IO, Piskin T, Duman E, Firat A, et al
    A Novel Technique in The Treatment of Lymphoceles After Renal Transplantation: C-arm Cone Beam CT-Guided Percutaneous Embolization of Lymphatic Leakage Following Lymphangiography.
    Transplantation. 2018 May 11. doi: 10.1097/TP.0000000000002268.
    >> Share

  2. AMAHAZION F
    Renal Replacement Therapy in Eritrea.
    Transplantation. 2018;102:707-710.
    >> Share

    April 2018
  3. MCADAMS-DEMARCO MA, Ying H, Thomas AG, Warsame F, et al
    Frailty, Inflammatory Markers, and Waitlist Mortality Among Patients with End-Stage Renal Disease in a Prospective Cohort Study.
    Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002213.
    >> Share

    March 2018
  4. HABBOUS S, McArthur E, Dixon SN, McKenzie S, et al
    Initiating maintenance dialysis prior to living kidney donor transplantation when a donor candidate evaluation is well underway.
    Transplantation. 2018 Mar 10. doi: 10.1097/TP.0000000000002159.
    >> Share

  5. VAN BUREN M, Lely T, van de Wetering J
    Essential Issues for Pregnancy Counseling in Renal Transplant Women.
    Transplantation. 2018 Mar 8. doi: 10.1097/TP.0000000000002164.
    >> Share

    February 2018
  6. ADELMANN D, Olmos A, Liu LL, Feiner JR, et al
    Intraoperative management of liver transplant patients without the routine use of renal replacement therapy.
    Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002137.
    >> Share


  7. Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs: Erratum.
    Transplantation. 2018;102:e88.
    >> Share

    January 2018
  8. MCCAULEY M, Mussell A, Goldberg D, Sawinski D, et al
    Race, Risk, and Willingness of End-stage Renal Disease Patients Without Hepatitis C (HCV) to Accept an HCV-infected Kidney Transplant.
    Transplantation. 2018 Jan 18. doi: 10.1097/TP.0000000000002099.
    >> Share

  9. POSTALCIOGLU M, Kaze AD, Byun BC, Siedlecki A, et al
    Association of Cold Ischemia Time with Acute Renal Transplant Rejection.
    Transplantation. 2018 Jan 18. doi: 10.1097/TP.0000000000002106.
    >> Share

  10. HOTTA K, Oura T, Dehnadi A, Boskovic S, et al
    Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation.
    Transplantation. 2018 Jan 4. doi: 10.1097/TP.0000000000002078.
    >> Share

  11. CULLARO G, Pisa JF, Brown RS Jr, Wagener G, et al
    Early Postoperative Neutrophil Gelatinase Associated Lipocalin Predicts the Development of Chronic Kidney Disease Following Liver Transplantation.
    Transplantation. 2018 Jan 3. doi: 10.1097/TP.0000000000002075.
    >> Share

    December 2017
  12. PRUTHI R, Tonkin-Crine S, Calestani M, Leydon G, et al
    Variation in Practice Patterns for Listing Patients for Renal Transplantation in the United Kingdom: a National Survey.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002046.
    >> Share

  13. COGNARD N, Anglicheau D, Gatault P, Girerd S, et al
    Recurrence of renal cell cancer after renal transplantation in a multicenter French cohort.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002009.
    >> Share

  14. WALL AE, Veale JL, Melcher ML
    Advanced Donation Programs and Deceased Donor-Initiated Chains-2 Innovations in Kidney Paired Donation.
    Transplantation. 2017;101:2818-2824.
    >> Share

  15. BERTSIMAS D, Kung J, Trichakis N, Wojciechowski D, et al
    Accept or Decline? An Analytics-Based Decision Tool for Kidney Offer Evaluation.
    Transplantation. 2017;101:2898-2904.
    >> Share

    November 2017
  16. WITZKE O, Nitschke M, Bartels M, Wolters H, et al
    Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: Long-term results after 7 years of a randomized clinical trial.
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002024.
    >> Share

  17. GRODSTEIN EI, Baggett N, Wayne S, Leverson G, et al
    An Evaluation of the Safety and Efficacy of Simultaneous Bilateral Nephrectomy and Renal Transplantation for Polycystic Kidney Disease: A 20-Year Experience.
    Transplantation. 2017;101:2774-2779.
    >> Share

    October 2017
  18. GREEN H, Lichtenberg S, Rahamimov R, Livneh A, et al
    Familial Mediterranean Fever Is Associated With Increased Mortality After Kidney Transplantation-A 19 Years' Single Center Experience.
    Transplantation. 2017;101:2621-2626.
    >> Share

  19. CHANDAK P, Kessaris N, Callaghan CJ, Calder F, et al
    Insights in Transplanting Complex Pediatric Renal Recipients With Vascular Anomalies.
    Transplantation. 2017;101:2562-2570.
    >> Share

    September 2017
  20. GEORGE RP
    Urinary biomarker CXCL10, identifying site specific allograft inflammation in renal transplantation.
    Transplantation. 2017 Sep 29. doi: 10.1097/TP.0000000000001960.
    >> Share

  21. SCHMIDT BMW, Sugianto RI, Thurn D, Azukaitis K, et al
    Early effects of renal replacement therapy on cardiovascular comorbidity in children with end-stage kidney disease: findings from the 4C-T Study.
    Transplantation. 2017 Sep 18. doi: 10.1097/TP.0000000000001948.
    >> Share

  22. HO J, Schaub S, Wiebe C, Gao A, et al
    Urinary CXCL10 chemokine is associated with alloimmune and virus compartment-specific renal allograft inflammation.
    Transplantation. 2017 Sep 12. doi: 10.1097/TP.0000000000001931.
    >> Share

  23. SAWINSKI D, Lim MA, Cohen JC, Locke JE, et al
    Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001930.
    >> Share

  24. AVETTAND-FENOEL V, Rouzioux C, Legendre C, Canaud G, et al
    HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and Transplantation.
    Transplantation. 2017;101:2003-2008.
    >> Share

    August 2017
  25. LEVI C, Fremeaux-Bacchi V, Zuber J, Rabant M, et al
    Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
    Transplantation. 2017 Aug 25. doi: 10.1097/TP.0000000000001909.
    >> Share

    July 2017
  26. PETERS-SENGERS H, Heemskerk MBA, Geskus RB, Kers J, et al
    Validation of the Prognostic Kidney Donor Risk Index (KDRI) Scoring System of Deceased Donors for Renal Transplantation in the Netherlands.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001889.
    >> Share

    June 2017
  27. FELTRAN LS, Varela P, Silva ED, Veronez CL, et al
    Targeted Next-generation Sequencing in Brazilian Children With Nephrotic Syndrome Submitted to Renal Transplant.
    Transplantation. 2017 Jun 28. doi: 10.1097/TP.0000000000001846.
    >> Share

  28. RAMESSUR CHANDRAN S, Han Y, Tesch GH, Di Paolo J, et al
    Inhibition of spleen tyrosine kinase reduces renal allograft injury in a rat model of acute antibody-mediated rejection in sensitized recipients.
    Transplantation. 2017 Jun 7. doi: 10.1097/TP.0000000000001826.
    >> Share

  29. NEWMAN KL, Lynch RJ, Adams AB, Zhang R, et al
    Hospitalization Among Individuals Waitlisted for Kidney Transplant.
    Transplantation. 2017 Jun 6. doi: 10.1097/TP.0000000000001839.
    >> Share

  30. CHHABRA AY, Leventhal J, Merchak AR, Ildstad S, et al
    HSCT Based Approaches for Tolerance Induction in Renal Transplant.
    Transplantation. 2017 Jun 1. doi: 10.1097/TP.0000000000001837.
    >> Share

  31. MOLNAR MZ, Nguyen DV, Chen Y, Ravel V, et al
    Predictive Score for Posttransplantation Outcomes.
    Transplantation. 2017;101:1353-1364.
    >> Share

    May 2017
  32. SINGH N, Dies D, Samant H
    Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Transplantation. 2017;101:e192.
    >> Share

    April 2017
  33. EGELAND EJ, Robertsen I, Hermann M, Midtvedt K, et al
    High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation.
    Transplantation. 2017 Apr 27. doi: 10.1097/TP.0000000000001796.
    >> Share

  34. MARTIN MT, Koppe S
    Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on Hemodialysis.
    Transplantation. 2017 Apr 3. doi: 10.1097/TP.0000000000001758.
    >> Share

  35. CHITTKA D, Hutchinson JA
    Pregnancy After Renal Transplantation.
    Transplantation. 2017;101:675-678.
    >> Share

  36. JAY CL, Washburn K, Dean PG, Helmick RA, et al
    Survival Benefit in Older Patients Associated With Earlier Transplant With High KDPI Kidneys.
    Transplantation. 2017;101:867-872.
    >> Share

    March 2017
  37. LAHAM G, Soler Pujol G, Vilches A, Cusumano A, et al
    Nonprogrammed vascular access is associated with greater mortality in patients who return to hemodialysis with a failing renal graft.
    Transplantation. 2017 Mar 28. doi: 10.1097/TP.0000000000001751.
    >> Share

  38. STEWART DE, Garcia VC, Rosendale JD, Klassen DK, et al
    Diagnosing the Decades-Long Rise in the Deceased Donor Kidney Discard Rate in the United States.
    Transplantation. 2017;101:575-587.
    >> Share

    February 2017
  39. VERNA EC, Brown RS Jr
    HCV Antiviral Therapy In Liver Transplant Candidates and Recipients with Renal Insufficiency.
    Transplantation. 2017 Feb 16. doi: 10.1097/TP.0000000000001688.
    >> Share

  40. DAHLE DO, Grotmol T, Leivestad T, Hartmann A, et al
    Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.
    Transplantation. 2017 Feb 15. doi: 10.1097/TP.0000000000001659.
    >> Share

  41. O'SHAUGHNESSY MM, Liu S, Montez-Rath ME, Lafayette RA, et al
    Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.
    Transplantation. 2017 Feb 15. doi: 10.1097/TP.0000000000001657.
    >> Share

  42. ROBERTS V, Campbell DJ, Lu B, Chia J, et al
    The differential effect of apyrase treatment and hCD39 overexpression on chronic renal fibrosis following ischemia reperfusion injury.
    Transplantation. 2017 Feb 14. doi: 10.1097/TP.0000000000001679.
    >> Share

    January 2017
  43. MARTENS GR, Reyes LM, Butler JR, Ladowski JM, et al
    Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells from GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001646.
    >> Share

  44. PICCOLI GB, Cabiddu G, Attini R, Gerbino M, et al
    Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis.
    Transplantation. 2017 Jan 21. doi: 10.1097/TP.0000000000001645.
    >> Share

  45. YAZDANI S, Naesens M
    Foretelling Graft Outcome by Molecular Evaluation of Renal Allograft Biopsies: The GoCAR Study.
    Transplantation. 2017;101:5-7.
    >> Share

    December 2016
  46. WAISER J, Duerr M, Budde K, Rudolph B, et al
    Treatment of Acute Antibody-Mediated Renal Allograft Rejection with Cyclophosphamide.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001617.
    >> Share

  47. LUBETZKY M, Chun S, Joelson A, Coco M, et al
    Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients with Directly Acting Antiviral Agents.
    Transplantation. 2016 Dec 22. doi: 10.1097/TP.0000000000001618.
    >> Share

  48. REKERS NV, Flaig TM, Mallat MJ, Spruyt-Gerritse MJ, et al
    Donor genotype and intragraft expression of CYP3A5 reflect the response to steroid treatment during acute renal allograft rejection.
    Transplantation. 2016.
    >> Share

  49. LONNING K, Midtvedt K, Leivestad T, Reisaeter AV, et al
    Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
    Transplantation. 2016;100:2705-2709.
    >> Share

  50. OSHIMA S, Karrer EE, Kawato Y, Maeda M, et al
    The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman Primates.
    Transplantation. 2016;100:2611-2620.
    >> Share

  51. SUTHERLAND AI
    Renal Transplantation in OCTOGENARIANS-A Real Proposition?
    Transplantation. 2016;100:2519-2520.
    >> Share

    October 2016
  52. DAVID-NETO E, Agena F, Ramos F, Triboni AH, et al
    Longitudinal Pharmacokinetics of Everolimus when Combined with Low-level of Tacrolimus in Elderly Renal Transplant Recipients.
    Transplantation. 2016.
    >> Share

  53. MCADAMS-DEMARCO MA, Ying H, Olorundare I, King EA, et al
    Individual Frailty Components and Mortality In Kidney Transplant Recipients.
    Transplantation. 2016.
    >> Share

  54. ZALTZMAN JS
    Is there a role for mTOR inhibitors in renal transplantation?
    Transplantation. 2016.
    >> Share

    September 2016
  55. CHEN L, Liberatore L, Chin T, Walker S, et al
    The Impact of Total Gastrectomy on Pharmacokinetics in Kidney Transplant Immunosuppressive Drug Regimes: A Case Study.
    Transplantation. 2016.
    >> Share

  56. BAMOULID J, Roodenburg A, Staeck O, Wu K, et al
    Clinical Outcome of Patients with De Novo C1q-Binding Donor-Specific HLA Antibodies after Renal Transplantation.
    Transplantation. 2016.
    >> Share


  57. Prevalence and Risk Factors of Noncontrolled and Resistant Arterial Hypertension in Renal Transplant Recipients: Erratum.
    Transplantation. 2016;100:e54.
    >> Share


  58. Antithymocyte Globulin is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients: Erratum.
    Transplantation. 2016;100:e54.
    >> Share

  59. HIRT-MINKOWSKI P, Rush DN, Gao A, Hopfer H, et al
    Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
    Transplantation. 2016;100:1988-96.
    >> Share

    August 2016
  60. PERRIN P, Kiener C, Javier RM, Braun L, et al
    Recent changes in chronic kidney disease-mineral and bone disorders (CKD-MBD) and associated fractures after kidney transplantation.
    Transplantation. 2016.
    >> Share

  61. KIM IK, Choi J, Vo AA, Kang A, et al
    Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients.
    Transplantation. 2016.
    >> Share

  62. CHOW KV, Flint SM, Shen A, Landgren A, et al
    Histological and Extended Clinical Outcomes Following ABO-incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Transplantation. 2016.
    >> Share

  63. EISENBERGER U, Guberina H, Willuweit K, Bienholz A, et al
    Successful treatment of chronic hepatitis C virus infection with sofosbuvir and ledipasvir in renal transplant recipients.
    Transplantation. 2016.
    >> Share

  64. SOARES KC, Arend LJ, Lonze BE, Desai NM, et al
    Successful Renal Transplantation of Deceased Donor Kidneys With 100% Glomerular Fibrin Thrombi and Acute Renal Failure Due To Disseminated Intravascular Coagulation.
    Transplantation. 2016.
    >> Share

  65. BONANI M, Pereira RM, Misselwitz B, Fehr T, et al
    Chronic norovirus infection as a risk factor for secondary lactose maldigestion in renal transplant recipients: a prospective parallel cohort pilot study.
    Transplantation. 2016.
    >> Share

  66. DAVID-NETO E, Romano P, Triboni AH, Ramos F, et al
    Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared to Younger recipients in the first 6 months after renal transplantation.
    Transplantation. 2016.
    >> Share

  67. SUTHERLAND A
    Renal transplantation in Octogenarians - a real proposition?
    Transplantation. 2016.
    >> Share

  68. FREEMAN MA, Pleis JR, Bornemann K, Croswell E, et al
    Has the Department of Veterans Affairs found a way to avoid racial disparities in the evaluation process for kidney transplantation?
    Transplantation. 2016.
    >> Share

  69. KABORE R, Couchoud C, Macher MA, Salomon R, et al
    Age dependent risk of graft failure in young kidney transplant recipients.
    Transplantation. 2016.
    >> Share

    July 2016
  70. SEGALL L, Nistor I, Pascual J, Mucsi I, et al
    Criteria For And Appropriateness Of Renal Transplantation In Elderly Patients With End-Stage Renal Disease: A Literature Review And Position Statement On Behalf Of The European Renal Association-European Dialysis And Transplant Association Descartes W
    Transplantation. 2016.
    >> Share

  71. LONNING K, Midtvedt K, Leivestad T, Reisaeter AV, et al
    Are octogenarians with end stage renal disease candidates for renal transplantation?
    Transplantation. 2016.
    >> Share

  72. GOODRICH NP, Schaubel DE, Smith AR, Merion RM, et al
    National Assessment of Hospitalization Rates for Incident End Stage Renal Disease after Liver Transplantation.
    Transplantation. 2016.
    >> Share

  73. ELDER GJ
    Decreased circulating sclerostin levels in renal transplant recipients with persistent hyperparathyroidism; who's conducting the orchestra?
    Transplantation. 2016.
    >> Share

  74. SAWINSKI D, Lee DH, Doyle AM, Blumberg EA, et al
    Successful Posttransplant Treatment of Hepatitis C with Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients.
    Transplantation. 2016.
    >> Share

  75. PEREZ-SAEZ MJ, Herrera S, Prieto-Alhambra D, Nogues X, et al
    Bone density, microarchitecture and tissue quality long-term after kidney transplant.
    Transplantation. 2016.
    >> Share

  76. SIMKINS J, Abbo LM, Camargo JF, Rosa R, et al
    Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
    Transplantation. 2016.
    >> Share

  77. EVENEPOEL P, Claes K, Viaene L, Bammens B, et al
    Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.
    Transplantation. 2016.
    >> Share

    June 2016
  78. LOLLINGA WT, de Wit RH, Rahbar A, Vasse GF, et al
    Human Cytomegalovirus-Encoded Receptor US28 Is Expressed in Renal Allografts and Facilitates Viral Spreading In Vitro.
    Transplantation. 2016.
    >> Share

  79. CRESPO E, Roedder S, Sigdel T, Hsieh SC, et al
    Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
    Transplantation. 2016.
    >> Share

  80. LINDAHL JP, Massey RJ, Hartmann A, Aakhus S, et al
    Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation.
    Transplantation. 2016.
    >> Share

    May 2016
  81. LIU S, Chaudhry MR, Berrebi AA, Papadimitriou JC, et al
    Polyomavirus Replication and Smoking Are Independent Risk Factors for Bladder Cancer After Renal Transplantation.
    Transplantation. 2016.
    >> Share

  82. HELLSTROM V, Lorant T, Dohler B, Tufveson G, et al
    High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer.
    Transplantation. 2016.
    >> Share

    April 2016
  83. O'REGAN JA, Prendeville S, McCaughan JA, Traynor C, et al
    Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    Transplantation. 2016.
    >> Share

  84. FRANK SJ, Walter WR, Latson L Jr, Cohen HW, et al
    New Dimensions in Renal Transplant Sonography: Applications of 3-Dimensional Ultrasound.
    Transplantation. 2016 Apr 21. doi: 10.1097/TP.0000000000001206.
    >> Share

  85. DE CARLIS L, Lauterio A, De Carlis R, Ferla F, et al
    Donation After Cardiac Death Liver Transplantation After More Than 20 Minutes of Circulatory Arrest and Normothermic Regional Perfusion.
    Transplantation. 2016;100:e21-2.
    >> Share

    March 2016
  86. DE LIMA JJ, Gowdak LH, de Paula FJ, Muela HC, et al
    Coronary Artery Disease Assessment and Intervention in Renal Transplant Patients: Analysis from the KiHeart Cohort.
    Transplantation. 2016.
    >> Share

  87. PILMORE H, Chadban S
    Cardiac Screening for Kidney Transplantation: The Clinical Conundrum Continues.
    Transplantation. 2016.
    >> Share

  88. ALHAMAD T, Brennan DC, Brifkani Z, Xiao H, et al
    Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications after Kidney Transplantation.
    Transplantation. 2016.
    >> Share

  89. VISENTIN J, Ramaharo D, Ryman A, Contin-Bordes C, et al
    Prevalence of IgA Antibodies to beta2-Glycoprotein I: A Population-Dependent Feature?
    Transplantation. 2016;100:e13-4.
    >> Share

    February 2016
  90. WYLD ML, Chadban SJ
    Recurrent IgA Nephropathy After Kidney Transplantation.
    Transplantation. 2016.
    >> Share

  91. NEWMAN KL, Fedewa SA, Jacobson MH, Adams AB, et al
    Racial/Ethnic Differences in the Association Between Hospitalization and Kidney Transplantation Among Waitlisted End-Stage Renal Disease Patients.
    Transplantation. 2016.
    >> Share

  92. COZZI E, Biancone L, Lopez-Fraga M, Nanni-Costa A, et al
    Long-term Outcome of Living Kidney Donation: Position Paper of the European Committee on Organ Transplantation, Council of Europe.
    Transplantation. 2016;100:270-1.
    >> Share

  93. CANAUD G, Delville M, Legendre C
    Recurrence of Focal and Segmental Glomerulosclerosis After Transplantation.
    Transplantation. 2016;100:284-7.
    >> Share

  94. CLAYTON PA
    Risky Business-Is the RoCKeT Ready to fly?
    Transplantation. 2016;100:268-9.
    >> Share

    November 2015
  95. MOLNAR MZ, Ravel V, Streja E, Kovesdy CP, et al
    Racial Differences in Survival of Incident Home Hemodialysis and Kidney Transplant Patients.
    Transplantation. 2015.
    >> Share

  96. SHIN JI, Palta M, Djamali A, Kaufman DB, et al
    The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).
    Transplantation. 2015.
    >> Share

    October 2015
  97. LAGING M, Kal-van Gestel JA, van de Wetering J, IJzermans JN, et al
    A High Comorbidity Score Should Not be a Contraindication for Kidney Transplantation.
    Transplantation. 2015.
    >> Share

    September 2015
  98. GATHOGO E, Harber M, Bhagani S, Levy J, et al
    Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Transplantation. 2015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016